FDA advisers vote to oppose Pfizer/BioNTech COVID-19 vaccine booster

By Manojna Maddipatla and Michael Erman Posted on September 17, 2021

FILE PHOTO: COVID-19 Vaccination of patients at their homes in Cologne

(Reuters) – A panel of outside advisers to the U.S. Food and Drug Administration on Friday voted against approval of a booster dose of the Pfizer Inc/BioNTech SE COVID-19 vaccine for people aged 16 and older.

(Reporting by Manojna Maddipatla in Bengaluru; Editing by Leslie Adler)

About the Author

More from our Sister Sites

A pedestrian passes by the US 4th Circuit Court of Appeals Courthouse on Main Street in Richmond, Va., Wednesday, June 16, 2021.

Gay City News

US Appeals Court revives trans girl’s challenge to statutory exclusion from girls’ sports teams

Friends, cleaning and recycling with people on beach for sustainability, environment and eco friendly. Climate change, earth day and nature with volunteer for community service, pollution and plastic

Caribbean Life

A date in celebration of Earth’s planetary rotation

Schneps Podcasts

Veselka’s 70th Anniversary with Ukranian Pride

Tailgate Sports

FDA advisers vote to oppose Pfizer/BioNTech COVID-19 vaccine booster

About the Author

Jobs in New York

Add your job

View all jobs…

Sports

News

More from our Sister Sites

US Appeals Court revives trans girl’s challenge to statutory exclusion from girls’ sports teams

A date in celebration of Earth’s planetary rotation

Veselka’s 70th Anniversary with Ukranian Pride

MLB Over/Under Bet of the Day: June 13, Royals vs Giants

FDA advisers vote to oppose Pfizer/BioNTech COVID-19 vaccine booster

About the Author

Sports

News

Related Articles

More from our Sister Sites

Home Pros

Things to do in NYC